Identification of EGFR mutations in lung sarcomatoid carcinoma.

作者信息

Leone Alvaro, Graziano Paolo, Gasbarra Rita, Paone Gregorino, Cardillo Giuseppe, Mancuso Andrea, De Marinis Filippo, Ricciardi Serena, Portalone Luigi, Pisa Roberto

出版信息

Int J Cancer. 2011 Feb 1;128(3):732-5; author reply 736. doi: 10.1002/ijc.25335.

DOI:10.1002/ijc.25335

PMID:20309946

Abstract

摘要

相似文献

Identification of EGFR mutations in lung sarcomatoid carcinoma.

Int J Cancer. 2011 Feb 1;128(3):732-5; author reply 736. doi: 10.1002/ijc.25335.

Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).

J Thorac Oncol. 2009 Jan;4(1):12-21. doi: 10.1097/JTO.0b013e3181913e28.

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.

Clin Cancer Res. 2004 Dec 15;10(24):8195-203. doi: 10.1158/1078-0432.CCR-04-1245.

The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases.

Clin Lung Cancer. 2012 Jul;13(4):288-96. doi: 10.1016/j.cllc.2011.11.004. Epub 2011 Dec 13.

[Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].

Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):686-90.

Mutation of epidermal growth factor receptor gene in adenosquamous carcinoma of the lung.

Lung Cancer. 2007 Jan;55(1):129-30. doi: 10.1016/j.lungcan.2006.09.003. Epub 2006 Dec 6.

Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma.

Cancer Cytopathol. 2013 Sep;121(9):500-7. doi: 10.1002/cncy.21288. Epub 2013 Mar 12.

High proportion of rare and compound epidermal growth factor receptor mutations in an Australian population of non-squamous non-small-cell lung cancer.

Intern Med J. 2014 Dec;44(12a):1188-92. doi: 10.1111/imj.12587.

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.

Clin Cancer Res. 2005 Jun 15;11(12):4289-94. doi: 10.1158/1078-0432.CCR-04-2506.

Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.

J Thorac Oncol. 2011 Apr;6(4):707-15. doi: 10.1097/JTO.0b013e31820a3a6b.

引用本文的文献

Analysis of molecular pathologic and clinical features of 36 patients with pulmonary sarcomatoid carcinoma.

BMC Pulm Med. 2022 Nov 29;22(1):453. doi: 10.1186/s12890-022-02248-9.

Clinical characteristics and prognostic factors of pulmonary sarcomatoid carcinoma.

J Thorac Dis. 2022 Oct;14(10):3773-3781. doi: 10.21037/jtd-22-393.

Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8 T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma.

Int J Gen Med. 2022 Apr 20;15:4209-4220. doi: 10.2147/IJGM.S357659. eCollection 2022.

Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification.

Clin Case Rep. 2021 Jul 23;9(7):e04487. doi: 10.1002/ccr3.4487. eCollection 2021 Jul.

Genomic origin and intratumor heterogeneity revealed by sequencing on carcinomatous and sarcomatous components of pulmonary sarcomatoid carcinoma.

Oncogene. 2021 Jan;40(4):821-832. doi: 10.1038/s41388-020-01573-9. Epub 2020 Dec 3.

Pulmonary pleomorphic carcinoma presenting as undifferentiated non-small cell carcinoma with giant cells: A case report and review of literature.

Respir Med Case Rep. 2020 Sep 14;31:101225. doi: 10.1016/j.rmcr.2020.101225. eCollection 2020.

Prognostic factors in patients undergoing pulmonary resection for sarcomatoid carcinomas of the lung.

Balkan Med J. 2021 Mar;38(2):104-110. doi: 10.4274/balkanmedj.galenos.2020.2020.7.45.

Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma.

Sci Rep. 2017 Jun 21;7(1):3947. doi: 10.1038/s41598-017-04296-2.

EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features.

Contemp Oncol (Pozn). 2015;19(1):22-7. doi: 10.5114/wo.2014.43491. Epub 2015 Mar 26.

Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report.

Oncol Lett. 2015 May;9(5):2239-2243. doi: 10.3892/ol.2015.3057. Epub 2015 Mar 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验